This observation, coupled with higher gene expression levels of acetylcholinesterase in DLB as compared with AD patients,47 led to the hypothesis that treatment with ChEI would be more effective in slowing cognitive decline in DLB compared to AD.48 The gene discussed is ACHE; the disease is Alzheimer disease.